Henry Khederian is a journalist who writes for Benzinga and Business Insider. His articles cover a wide range of topics in the business and finance sector, including stocks, investments, and market trends. With a focus on providing up-to-date information and analysis, Henry aims to keep readers informed about the latest developments in the business world.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
This information evolves through machine learning and human feedback. Improve this profile .
Zinger Key Points SaverOne shares are trading sharply higher after the company announced a pilot with System Logistics.
Zinger Key Points Abercrombie & Fitch Co (NYSE: ANF) shares hit a new 52-week high Monday.
By: Henry Khederian
SenesTech Inc (NASDAQ: SNES) shares are trading lower by 36% to $1.18 Tuesday morning after the company priced a public offering of around 3.8 million shares of common stock at $1.30 per share, alongside warrants for
By: Henry Khederian
Biodexa Pharmaceuticals PLC-ADR (NASDAQ: BDRX) shares are trading lower by 6.8% to $4.76 Tuesday morning after the company announced an offering of 1,397,849 Class A Units at an assumed public offering price of $2.79 per Class A Unit in a preliminary prospectus.
Zinger Key Points The company priced an underwritten public offering late Monday. The company plans to use the net proceeds primarily for advancing TH104's phase 2 trial in 2024.
By: Henry Khederian
ChargePoint Holdings Inc (NASDAQ: CHPT) shares are trading lower by 6.3% to $1.86 Tuesday afternoon after UBS analyst Robert Jamieson downgraded the stock from Buy to Neutral and lowered the price target from $9 to $2.25.
ChargePoint Holdings Inc (NASDAQ:CHPT) shares are trading lower by 6.3% to $1.86 Tuesday afternoon after UBS analyst Robert Jamieson downgraded the stock from Buy to Neutral and lowered the price target from $9 to $2.25.
Zinger Key Points iBio recently approved a 20-to-1 reverse stock split of its common stock. Fractional shareholders will receive cash payments.
Zinger Key Points nLIGHT on Monday announced a $34.5 million contract for DE M-SHORAD laser weapon system. The approval serves as a "License to Operate."
Zinger Key Points Verve Therapeutics priced its proposed public offering of common stock and concurrent private placement.
(833) 317-6278 
